Impossibility to export biosimilar drug price at 30% of foreign prices

In order for biopharmaceutical products, which have been chosen as a new growth industrial power by the government, to have expansion and leadership in the global market, the biopharmaceutical industry has raised a strong voice to promptly address price of biopharmaceutical products.

When a global biopharmaceutical product is expanded into a market, its import price and health insurance benefi...